Einstein/Montefiore Department of Medicine

Grand Rounds

Medicine Grand Rounds: Asthma Phenotypes and Their Implications for Personalized Treatment

Einstein/Montefiore Department of Medicine Grand Rounds

Thursday, April 14, 2016

8:00 AM: Forchheimer Medical Science Building 3rd Floor Lecture Hall

Speaker & Info

Larry Borish, MD
Professor of Medicine and Microbiology
Department of Medicine, Division of Allergy and Clinical Immunology
University of Virginia Health System

Repeated at 12:15 pm, Cherkasky Auditorium, Montefiore Medical Center.

Dr. Larry Borish did his undergraduate work at Harvard College where he received his B.A. cum laude in music in 1975. He received his M.D. from Boston University in 1979, then returned to Harvard for an internal medicine residency, completed in 1982. He completed clinical training in allergy/immunology at the New England Medical Center followed by several years of post-doctoral fellowship training in research in the laboratories of Drs. Ross Rocklin and Lanny Rosenwasser.

Dr. Borish was a faculty member at Tufts Medical School prior to his move to Colorado in 1989. From 1989 to 1999 he was an Associate Professor of Medicine at the U. Colorado Health Sciences Center and a staff physician/principal investigator at the National Jewish Medical and Research Center. He is currently a Professor of Medicine and Microbiology at the University of Virginia and holds appointments in the Asthma and Allergic Diseases Center, the University of Virginia Cancer Center, and the Carter Immunology Center. He has served as chair of the FDA advisory board on Allergenic Products and has been a member of several National Institutes of Health grant review study sections. He has been on the editorial boards for the Journal of Allergy and Clinical Immunology, Am. J. Rhinology and Allergy, and Clinical and Experimental Allergy.

Dr. Borish's laboratory research interests involve mechanisms controlling the production and actions of chemical mediators of asthma and sinusitis. These studies are focused in part in identifying the molecular basis of aspirin intolerance in patients with aspirin-exacerbated asthma and sinusitis. Dr. Borish's laboratory also focuses on the interplay between sinusitis and asthma and mechanisms by which sinus disease can cause and exacerbate asthma. More recently his focus has turned to immunological mechanisms of the immune response to rhinovirus that underlie asthma exacerbations. His clinical interests include chronic sinusitis, severe asthma, aspirin-exacerbated respiratory disease, primary immune deficiencies, and autoimmune mechanisms in chronic urticaria (hives).

Objectives - After attending this activity, participants will be able to:

  1. Describe the different phenotypes of asthma and the requirement for disease-specific therapeutics
  2. Describe novel targets for potential asthma therapeutics - and why they may not work either
  3. Appreciate the distinct and complementary roles of innate (lung) and adaptive (T+B) cell components driving asthma pathogenesis

Accreditation: Albert Einstein College of Medicine designates this educational activity for a maximum of 1 credit towards the AMA Physician's Recognition Award. Each physician should claim only those credits that he/she actually spent in the educational activity. Albert Einstein College of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Host: Division of Allergy and Immunology (Department of Medicine)

Click here to log in